Detailed Information on Publication Record
2016
CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
BRYJA, Vítězslav, Markéta KAUCKÁ, Karla PLEVOVÁ, Šárka PAVLOVÁ, Šárka POSPÍŠILOVÁ et. al.Basic information
Original name
CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Authors
BRYJA, Vítězslav (203 Czech Republic, guarantor, belonging to the institution), Markéta KAUCKÁ (203 Czech Republic, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), Šárka PAVLOVÁ (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Alois KOZUBÍK (203 Czech Republic, belonging to the institution)
Edition
Number: EP2882437 (B1), Publisher: European patent Office, Place of publication: Mnichov, Owner's name: MASARYKOVA UNIVERZITA, 2016
Other information
Language
English
Type of outcome
Patent
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14740/16:00088788
Organization unit
Central European Institute of Technology
Keywords in English
casein kinase 1; lymphocytic leukemia; B-cell
Tags
Změněno: 22/3/2017 10:30, Mgr. Eva Špillingová
Abstract
V originále
The invention relates to inhibitors of casein kinase 1 for use in the treatment of B-cell chronic lymphocytic leukemia.
Links
GAP301/11/0747, research and development project |
| ||
MSM0021622430, plan (intention) |
| ||
NT11217, research and development project |
|